Key result
In gBRCA1/2 mutation carriers, greater adherence to the Mediterranean diet was associated with reduced odds for metabolic syndrome, while a pessimistic outlook increased the odds.
Why the study?
Germline BRCA1/2 mutation carriers have an elevated breast cancer risk and often undergo severe cancer treatments, but little is known about associations between dietary intake and HRQoL in this population.
Does dietary intake relate to dispositional optimism and health-related quality of life in germline BRCA1/2 mutation carriers?
Cross-Sectional (n=312)
Does dietary intake relate to dispositional optimism and health-related quality of life in germline BRCA1/2 mutation carriers?
Answers are grounded in this paper and cite their sources.
In gBRCA1/2 mutation carriers, greater adherence to the Mediterranean diet is associated with a more optimistic outlook, lower dietary inflammatory index, and reduced odds of metabolic syndrome.
Background: The Mediterranean diet (MD) is an anti-inflammatory diet linked to improved health-related quality of life (HRQoL). Germline (g)BRCA1/2 mutation carriers have an increased risk of developing breast cancer and are often exposed to severe cancer treatments, thus the improvement of HRQoL is important. Little is known about the associations between dietary intake and HRQoL in this population. Methods: We included 312 gBRCA1/2 mutation carriers from an ongoing prospective randomized controlled lifestyle intervention trial. Baseline data from the EPIC food frequency questionnaire was used to calculate the dietary inflammatory index (DII), and adherence to MD was captured by the 14-item PREDIMED questionnaire. HRQoL was measured by the EORTC QLQ-C30 and LOT-R questionnaires. The presence of metabolic syndrome (MetS) was determined using anthropometric measurements, blood samples and vital parameters. Linear and logistic regression models were performed to assess the possible impact of diet and metabolic syndrome on HRQoL. Results: Women with a prior history of cancer (59.6%) reported lower DIIs than women without it (p = 0.011). A greater adherence to MD was associated with lower DII scores (p < 0.001) and reduced odds for metabolic syndrome (MetS) (p = 0.024). Women with a more optimistic outlook on life reported greater adherence to MD (p < 0.001), whereas a more pessimistic outlook on life increased the odds for MetS (OR = 1.15; p = 0.023). Conclusions: This is the first study in gBRCA1/2 mutation carriers that has linked MD, DII, and MetS to HRQoL. The long-term clinical implications of these findings are yet to be determined.
No takes yet. Share an insight, caveat, or question.
Esser et al. (2023) conducted a cross-sectional in gBRCA1/2 mutation carriers (n=312). Mediterranean diet adherence and dispositional optimism vs. Lower adherence / pessimistic outlook was evaluated on Metabolic syndrome (MetS) (OR 1.15, p=0.023). In gBRCA1/2 mutation carriers, greater adherence to the Mediterranean diet was associated with reduced odds for metabolic syndrome, while a pessimistic outlook increased the odds.
Synapse has enriched 10 related papers. Consider them for comparative context: